Gossamer Bio, Inc. (GOSS)
8.77
-0.12
(-1.35%)
USD |
NASDAQ |
Oct 16, 16:00
8.77
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Net Income (TTM) : -125.22M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -125.22M |
| March 31, 2026 | -180.40M |
| December 31, 2025 | -170.37M |
| September 30, 2025 | -156.16M |
| June 30, 2025 | -138.74M |
| March 31, 2025 | -51.24M |
| December 31, 2024 | -56.53M |
| September 30, 2024 | -71.65M |
| June 30, 2024 | -80.85M |
| March 31, 2024 | -172.58M |
| December 31, 2023 | -179.82M |
| September 30, 2023 | -187.43M |
| June 30, 2023 | -206.79M |
| March 31, 2023 | -220.76M |
| December 31, 2022 | -229.38M |
| September 30, 2022 | -229.90M |
| June 30, 2022 | -230.78M |
| Date | Value |
|---|---|
| March 31, 2022 | -234.15M |
| December 31, 2021 | -234.00M |
| September 30, 2021 | -242.32M |
| June 30, 2021 | -239.89M |
| March 31, 2021 | -246.93M |
| December 31, 2020 | -243.36M |
| September 30, 2020 | -233.45M |
| June 30, 2020 | -224.14M |
| March 31, 2020 | -201.77M |
| December 31, 2019 | -180.31M |
| September 30, 2019 | -164.40M |
| June 30, 2019 | -165.30M |
| March 31, 2019 | -153.54M |
| December 31, 2018 | -146.97M |
| September 30, 2018 | -114.62M |
| June 30, 2018 | -65.51M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| United Therapeutics Corp. | 1.311B |
| Arbutus Biopharma Corp. | 153.05M |
| Kura Oncology, Inc. | -296.78M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |